Latest digoxin Stories
OAKLAND, Calif., Nov.
We are advised by Kaiser Permanente that journalists and other readers should disregard the news release, Digoxin Associated With Higher Risk of Death and Hospitalization in Adults With Atrial Fibrillation
OAKLAND, Calif., Oct.
CARY, N.C., Feb.
WOODCLIFF LAKE, N.J., Jan. 16, 2014 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has entered into an exclusive U.S.
For decades, doctors have understood that microbes in the human gut can influence how certain drugs work in the body — by either activating or inactivating specific compounds — but questions have remained about exactly how the process works.
A study published today in the European Heart Journal found no evidence that digoxin increases mortality in patients with atrial fibrillation (AF), the opposite of results just published by another group in the same journal analyzing the same data.
Researchers recently discovered that digoxin, a drug commonly utilized in heart disease treatments, could heighten the risk of death for patients who suffer from atrial fibrillation.